176 related articles for article (PubMed ID: 32283163)
1. A potential inhibitory role for integrin in the receptor targeting of SARS-CoV-2.
Luan J; Lu Y; Gao S; Zhang L
J Infect; 2020 Aug; 81(2):318-356. PubMed ID: 32283163
[No Abstract] [Full Text] [Related]
2. Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein.
Xia S; Zhu Y; Liu M; Lan Q; Xu W; Wu Y; Ying T; Liu S; Shi Z; Jiang S; Lu L
Cell Mol Immunol; 2020 Jul; 17(7):765-767. PubMed ID: 32047258
[No Abstract] [Full Text] [Related]
3. SARS, MERS and SARS-CoV-2 (COVID-19) treatment: a patent review.
Nascimento Junior JAC; Santos AM; Quintans-Júnior LJ; Walker CIB; Borges LP; Serafini MR
Expert Opin Ther Pat; 2020 Aug; 30(8):567-579. PubMed ID: 32429703
[TBL] [Abstract][Full Text] [Related]
4.
Prasun P
J Interferon Cytokine Res; 2020 Sep; 40(9):466-467. PubMed ID: 32744884
[No Abstract] [Full Text] [Related]
5. Cholesterol 25-Hydroxylase inhibits SARS-CoV-2 and other coronaviruses by depleting membrane cholesterol.
Wang S; Li W; Hui H; Tiwari SK; Zhang Q; Croker BA; Rawlings S; Smith D; Carlin AF; Rana TM
EMBO J; 2020 Nov; 39(21):e106057. PubMed ID: 32944968
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options for the 2019 novel coronavirus (2019-nCoV).
Li G; De Clercq E
Nat Rev Drug Discov; 2020 Mar; 19(3):149-150. PubMed ID: 32127666
[No Abstract] [Full Text] [Related]
7. SARS-CoV-2 and Multiple Sclerosis: Not All Immune Depleting DMTs are Equal or Bad.
Amor S; Baker D; Khoury SJ; Schmierer K; Giovanonni G
Ann Neurol; 2020 Jun; 87(6):794-797. PubMed ID: 32383812
[No Abstract] [Full Text] [Related]
8. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor.
Hoffmann M; Kleine-Weber H; Schroeder S; Krüger N; Herrler T; Erichsen S; Schiergens TS; Herrler G; Wu NH; Nitsche A; Müller MA; Drosten C; Pöhlmann S
Cell; 2020 Apr; 181(2):271-280.e8. PubMed ID: 32142651
[TBL] [Abstract][Full Text] [Related]
9. Impact of corticosteroid therapy on outcomes of persons with SARS-CoV-2, SARS-CoV, or MERS-CoV infection: a systematic review and meta-analysis.
Li H; Chen C; Hu F; Wang J; Zhao Q; Gale RP; Liang Y
Leukemia; 2020 Jun; 34(6):1503-1511. PubMed ID: 32372026
[TBL] [Abstract][Full Text] [Related]
10. Emergence, Transmission, and Potential Therapeutic Targets for the COVID-19 Pandemic Associated with the SARS-CoV-2.
Patil AM; Göthert JR; Khairnar V
Cell Physiol Biochem; 2020 Aug; 54(4):767-790. PubMed ID: 32830930
[TBL] [Abstract][Full Text] [Related]
11. Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus.
Martinez MA
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32152082
[TBL] [Abstract][Full Text] [Related]
12. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19.
Huang Y; Yang C; Xu XF; Xu W; Liu SW
Acta Pharmacol Sin; 2020 Sep; 41(9):1141-1149. PubMed ID: 32747721
[TBL] [Abstract][Full Text] [Related]
13. Remdesivir against COVID-19 and Other Viral Diseases.
Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
[TBL] [Abstract][Full Text] [Related]
14. The role of IgG Fc receptors in antibody-dependent enhancement.
Bournazos S; Gupta A; Ravetch JV
Nat Rev Immunol; 2020 Oct; 20(10):633-643. PubMed ID: 32782358
[TBL] [Abstract][Full Text] [Related]
15.
Sachdeva C; Wadhwa A; Kumari A; Hussain F; Jha P; Kaushik NK
OMICS; 2020 Oct; 24(10):568-580. PubMed ID: 32757981
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme 2: The old door for new severe acute respiratory syndrome coronavirus 2 infection.
Tan HW; Xu YM; Lau ATY
Rev Med Virol; 2020 Sep; 30(5):e2122. PubMed ID: 32602627
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human ACE2: potential therapeutics of SARS-CoV-2 infection and its complication.
Pang X; Cui Y; Zhu Y
Acta Pharmacol Sin; 2020 Sep; 41(9):1255-1257. PubMed ID: 32581256
[No Abstract] [Full Text] [Related]
18. Salvianolic acid C potently inhibits SARS-CoV-2 infection by blocking the formation of six-helix bundle core of spike protein.
Yang C; Pan X; Xu X; Cheng C; Huang Y; Li L; Jiang S; Xu W; Xiao G; Liu S
Signal Transduct Target Ther; 2020 Oct; 5(1):220. PubMed ID: 33024075
[No Abstract] [Full Text] [Related]
19. Novel Drugs Targeting the SARS-CoV-2/COVID-19 Machinery.
Sternberg A; McKee DL; Naujokat C
Curr Top Med Chem; 2020; 20(16):1423-1433. PubMed ID: 32416679
[TBL] [Abstract][Full Text] [Related]
20. Controversies of renin-angiotensin system inhibition during the COVID-19 pandemic.
South AM; Tomlinson L; Edmonston D; Hiremath S; Sparks MA
Nat Rev Nephrol; 2020 Jun; 16(6):305-307. PubMed ID: 32246101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
